Abonnement à la biblothèque: Guest
Portail numérique Bibliothèque numérique eBooks Revues Références et comptes rendus Collections
Critical Reviews™ in Eukaryotic Gene Expression
Facteur d'impact: 1.841 Facteur d'impact sur 5 ans: 1.927 SJR: 0.649 SNIP: 0.516 CiteScore™: 1.96

ISSN Imprimer: 1045-4403
ISSN En ligne: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukaryotGeneExpr.2017019527
pages 289-295

Phage Therapy against Streptococcus pneumoniae: Modern Tool to Control Pneumonia

Muhammad Imran Qadir
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Bosan Road, Multan, Pakistan
Sahir Sajjad
Institute of Molecular Biology and Biotechnology, Bahauddin Zakariya University, Multan Pakistan

RÉSUMÉ

Phage therapy is important for treatment of drug-resistant pathogens as compared to antibiotics in this modern era. Since 1966, bacteriophages have been used as antibacterial agents and played a very crucial role in the expansion of molecular biology. Bacteriophages have been used to treat infection in Western medicine along with antibiotics. Antibacterial agents against the antibiotic resistance strains have been discovered. The lytic bacteriophage used for treatment in conventional phage therapy have shown hopeful results in human clinical cases. In animal models and in vitro studies, phages are used as therapeutics. Bacterial pathogens decreased with use of dual therapy of antibiotics and phages. Variation in intracellular targets of the type II DNA topoisomerases acquired by recombination with the fluoroquinolones have shown resistance. This review summarizes the role of Streptococcus pneumoniae in phage therapy. The study condenses the biochemical and structural data described for Streptococcus. pneumoniae biofilms.


Articles with similar content:

Bacterial Toxins in Cancer Immunotherapy
Forum on Immunopathological Diseases and Therapeutics, Vol.4, 2013, issue 3-4
Lenka Sadilkova, Irena Adkins, Lenka Palova-Jelinkova
Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.33, 2016, issue 5
Shivani Saraf, Ankit Jain, Pooja Hurkat, Sanjay Kumar Jain
Immunotherapeutic Approaches to Head and Neck Cancer
Critical Reviews™ in Oncogenesis, Vol.23, 2018, issue 3-4
Hassan Nasser, Maie St. John
Effects of Benzalkonium Salts on Eukaryotic and Microbial G-Protein-Mediated Processes and Surface Membranes
Critical Reviews™ in Oncogenesis, Vol.6, 1995, issue 3-6
Roberto Patarca, Mary Ann Fletcher
Benzalkonium Salts: Effects on G Protein-Mediated Processes and Surface Membranes
Critical Reviews™ in Oncogenesis, Vol.11, 2000, issue 3&4
Alicia A. Zuniga, Roberto Patarca, Mary Ann Fletcher, Jason A. Rosenzweig